Literature DB >> 20920748

Genomic imprinting syndromes and cancer.

Derek Hock Kiat Lim1, Eamonn Richard Maher.   

Abstract

Genomic imprinting represents a form of epigenetic control of gene expression in which one allele of a gene is preferentially expressed according to the parent-of-origin of the allele. Genomic imprinting plays an important role in normal growth and development. Disruption of imprinting can result in a number of human imprinting syndromes and predispose to cancer. In this chapter, we describe a number of human imprinting syndromes to illustrate the concepts of genomic imprinting and how loss of imprinting of imprinted genes their relationship to human neoplasia.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20920748     DOI: 10.1016/B978-0-12-380866-0.60006-X

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  37 in total

1.  ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.

Authors:  Franck Bourdeaut; Sandrine Ferrand; Laurence Brugières; Marjorie Hilbert; Agnès Ribeiro; Ludovic Lacroix; Jean Bénard; Valérie Combaret; Jean Michon; Dominique Valteau-Couanet; Bertrand Isidor; Xavier Rialland; Maryline Poirée; Anne-Sophie Defachelles; Michel Peuchmaur; Gudrun Schleiermacher; Gaëlle Pierron; Marion Gauthier-Villars; Isabelle Janoueix-Lerosey; Olivier Delattre
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease.

Authors:  Caroline L Relton; George Davey Smith
Journal:  Int J Epidemiol       Date:  2012-02       Impact factor: 7.196

3.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.

Authors:  Dewi Astuti; Mark R Morris; Wendy N Cooper; Raymond H J Staals; Naomi C Wake; Graham A Fews; Harmeet Gill; Dean Gentle; Salwati Shuib; Christopher J Ricketts; Trevor Cole; Anthonie J van Essen; Richard A van Lingen; Giovanni Neri; John M Opitz; Patrick Rump; Irene Stolte-Dijkstra; Ferenc Müller; Ger J M Pruijn; Farida Latif; Eamonn R Maher
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

Review 4.  Epigenetic alterations in inflammatory bowel disease and cancer.

Authors:  Joo Mi Yi; Tae Oh Kim
Journal:  Intest Res       Date:  2015-04-27

Review 5.  Pluripotency of male germline stem cells.

Authors:  Sungtae Kim; Juan Carlos Izpisua Belmonte
Journal:  Mol Cells       Date:  2011-03-24       Impact factor: 5.034

Review 6.  The tumorigenicity of human embryonic and induced pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

Review 7.  Maternal-fetal conflict, genomic imprinting and mammalian vulnerabilities to cancer.

Authors:  David Haig
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

Review 8.  Oncogenic potential of yin yang 1 mediated through control of imprinted genes.

Authors:  Michelle M Thiaville; Joomyeong Kim
Journal:  Crit Rev Oncog       Date:  2011

9.  Genomic imprinting at a boundary element flanking the SDHD locus.

Authors:  Bora E Baysal; Sharen E McKay; Yoon Jung Kim; Zimei Zhang; Linda Alila; Joan E Willett-Brozick; Karel Pacak; Tae Hoon Kim; Gerald S Shadel
Journal:  Hum Mol Genet       Date:  2011-08-23       Impact factor: 6.150

10.  Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.

Authors:  Doaa Hashad; Amany Elbanna; Abeer Ibrahim; Gihan Khedr
Journal:  J Clin Lab Anal       Date:  2016-05-17       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.